Market Overview Global Neuromarketing Market size and share is currently valued at USD 1.44 billion in 2023 and is anticipated to generate an estimated revenue of USD 2.99 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 8.5% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 -...

The Maritime Surveillance and Intervention Market is evolving rapidly as global security concerns, territorial disputes, and maritime trade expansion continue to shape the demand for advanced monitoring and intervention systems. Nations across the world are strengthening their maritime defense capabilities to safeguard coastal borders, protect offshore assets, and combat illicit activities such...

Market Overview Global satellite solar cell materials market size and share is currently valued at USD 37.21 million in 2023 and is anticipated to generate an estimated revenue of USD 111.46 million by 2032 , according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 13.2% Compound Annual Growth Rate (CAGR) over the forecasted...

According to a new report by Polaris Market Research, the global Tremfya market was valued at USD 4.2 billion in 2025 and is projected to reach USD 7.99 billion by 2034, expanding at a CAGR of 7.40% over the forecast period, with 2026 market size estimated at USD 4.51 billion. Growth is underpinned by rising preference for biologic therapies over traditional systemic treatments, increasing...

According to a new report by Polaris Market Research, the global Tremfya market was valued at USD 4.2 billion in 2025 and is projected to reach USD 7.99 billion by 2034, expanding at a CAGR of 7.40% over the forecast period. Growth is underpinned by rising adoption of biologic therapies, expanding regulatory approvals across inflammatory indications, and accelerating investment in...

According to a new report by Polaris Market Research, the global Tremfya market was valued at USD 4.2 billion in 2025 and is projected to reach USD 7.99 billion by 2034, expanding at a CAGR of 7.40% over the forecast period. Growth is underpinned by rising adoption of biologic therapies, expanding regulatory approvals across inflammatory indications, and accelerating investment in...